Michelle McMurry-Heath, leader of the world's largest biotech advocacy organization, joins NTI's board of directors

Michelle McMurry-Heath, leader of the world’s largest biotech advocacy organization, joins NTI’s board of directors

Dr. Michelle McMurry-Heath, president and CEO of the Biotechnology Innovation Organization (BIO), the largest biotechnology organization in the world, joins the board of NTI, announced Ernest J. Moniz, co-president and CEO of NTI.

A global leader in science policy with a background in biosafety, McMurry-Heath is a physician and immunologist whose career spans government, the pharmaceutical industry and biotechnology. She focuses on expanding access to scientific advancement so that more patients from diverse backgrounds can benefit from cutting-edge advancements, which she calls “the social justice issue of our age.”

“We are honored to welcome Dr. McMurry-Heath to our board,” said Moniz. “He Will Lead to the NTI Board and to our NTI | bio program. We look forward to working with you to reduce global biological threats. “

Prior to joining BIO, McMurry-Heath held several senior positions at Johnson & Johnson and was a key science policy leader in the government, including the role of Associate Scientific Director of the Center for Devices and Radiological Health of Food and United States Drug Administration (FDA) under then – FDA Commissioner Margaret A. Hamburg, now a board member of NTI. McMurry-Heath was also founding director of the Aspen Institute’s Health, Biomedical Science, and Society Policy Program. She received her first training in science policy from the Robert Wood Johnson Foundation and later served as Senator Joe Lieberman’s principal legislative contributor for science and health, where she drafted legislation to protect the country from biological attacks.

McMurry-Heath received his MD / PhD from Duke’s Medical Scientist Training Program, becoming the first African American to graduate from the prestigious program.

“NTI has been committed to addressing biological threats since our foundation. A key priority for our NTI | bio team is safeguarding modern bioscience and biotechnology development to reduce the risks of accidental or deliberate misuse with potentially catastrophic consequences. We are fortunate to have Dr. McMurry-Heath helping lead this work, ”said Sam Nunn, co-chair and co-founder of NTI.

“Dr. McMurry-Heath has demonstrated longstanding leadership and commitment to promoting biosecurity throughout his career. His leadership on the NTI board of directors will help strengthen NTI | bio work and the impact on the field at a critical moment, ”added Hamburg.

Read Dr. McMurry-Heath’s full bio here.

The Nuclear Threat Initiative is a non-profit, non-partisan global security organization focused on reducing nuclear and biological threats that endanger humanity. NTI | bio promotes new ideas, experiments with solutions and supports change to address potentially catastrophic biological events on a global scale.

Leave a Comment

Your email address will not be published.